Butabarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Coadministration of CYP3A4 inducers may lessen sufentanil amounts and efficacy, quite possibly precipitating withdrawal syndrome in patients who may have formulated Actual physical dependence to sufentanil. Discontinuation of concomitantly made use of... https://cicill087ylp6.empirewiki.com/user